Reuters logo
BRIEF-Pharmasimple H1 EBITDA loss stable at 0.4 million euros
September 18, 2017 / 5:19 PM / 3 months ago

BRIEF-Pharmasimple H1 EBITDA loss stable at 0.4 million euros

Sept 18 (Reuters) - PHARMASIMPLE SA:

* H1 REVENUE EUR 9.5 MILLION VERSUS EUR 5.7 MILLION YEAR AGO‍​

* H1 EBITDA LOSS EUR 0.4 MILLION VERSUS LOSS OF EUR 0.4 MILLION YEAR AGO‍​

* H1 NET LOSS EUR 0.6 MILLION VERSUS LOSS EUR 0.5 MILLION YEAR AGO ‍​

* OUTLOOK FOR 2017: ACCELERATION IN ACTIVITY GROWTH IN H2 AND EXPECTED IMPROVEMENT IN PROFITABILITY‍​ Source text: bit.ly/2xtkPMA Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below